ENTELLUS MEDICAL INC

ENTELLUS MEDICAL INC insiders are currently net buyers of ENTL stock, showing neutral sentiment over the past 90 days. Executives have purchased $18.0M while selling $9.7M, resulting in a positive net flow of $8.3M. This buying activity represents 65% of total transaction volume.

ENTELLUS MEDICAL INC has 24 active insiders who have filed SEC Form 4 transactions in the past 90 days. Rock Partners Management Llc Split (Executive) leads with 7 transactions totaling $81.8M. Brian E. Farley (Executive) follows with 31 transactions worth $13.7M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. ENTELLUS MEDICAL INC's current score of 65/100 indicates neutral insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $18.0M in purchases versus $9.7M in sales.

The most recent insider transaction occurred on Feb 28, 2018, when Stryker Corp (Executive) disposed of 26,012,704 shares at $0.00 per share for $0. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, ENTL insider trading sentiment is currently neutral with an Alignment Score of 65/100. The net insider flow of $8.3M reflects accumulation, with 65% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like ENTELLUS MEDICAL INC. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At ENTL, we track all Form 4 filings—currently showing 123 transactions from 24 insiders over 90 days.

A 10b5-1 plan allows ENTELLUS MEDICAL INC executives to pre-schedule stock sales when they don't possess material non-public information. At ENTL, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at ENTL appears discretionary, making insider signals more meaningful.

You can monitor ENTELLUS MEDICAL INC (ENTL) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 24 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. ENTELLUS MEDICAL INC's current score of 65/100 indicates moderately bullish sentiment suggesting insider confidence. This is calculated from $18.0M in purchases versus $9.7M in sales over 90 days, resulting in a net flow of $8.3M.

SEC Form 4 filings are mandatory reports that ENTELLUS MEDICAL INC insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At ENTL, the most common type is "D" with 17 occurrences. The most recent Form 4 was filed on Feb 28, 2018 by Stryker Corp.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At ENTELLUS MEDICAL INC, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at ENTL represents discretionary decisions with more informational value.